Table 1 Patient characteristics
Characteristics | Myomectomy or subtotal hysterectomy (n = 15) | Hysterectomy (n = 30) |
|---|---|---|
Age (years) median (range) | 42 (27–54) | 47 (26–66) |
Gravidity, median (range) | 3 (0–6) | 3 (0–6) |
≤ 2 | 6 (40 %) | 9 (30 %) |
> 2 | 9 (60 %) | 21 (70 %) |
Parity, median (range) | 2 (0–3) | 2 (0–4) |
≤ 1 | 7 (46.7 %) | 7 (30.3 %) |
> 1 | 8 (53.3 %) | 23 (76.7 %) |
Menopause | ||
Yes | 4 (26.7 %) | 14 (46.7 %) |
No | 11 (73.3 %) | 16 (53.3 %) |
Previous cesarean section | ||
Yes | 3 (20 %) | 4 (13.3 %) |
No | 12 (80 %) | 26 (86.7 %) |
Mode of initial surgery | ||
Laparotomy | 9 (60 %) | 22 (73.3 %) |
Laparoscopy | 6 (40 %) | 8 (26.7 %) |
FIGO stage | ||
IA | 5 (33.3 %) | 7 (23.3 %) |
IB | 9 (60.0 %) | 22 (73.3 %) |
IIA | 1 (6.7 %) | 1 (3.3 %) |
Histology | ||
Leiomyosarcoma | 7 (46.7 %) | 11 (36.7 %) |
Endometrial stromal sarcoma | 7 (46.7 %) | 19 (63.3 %) |
Adenosarcoma | 1 (6.7 %) | 0 |
Morcellation* | ||
No | 11 (73.3 %) | 25 (83.3 %) |
Hand morcellation | 0 (0 %) | 5 (16.7 %) |
Power morcellation | 4 (26.7 %) | 0 (0 %) |
Surgical re-exploration* | ||
Yes | 14 (93.3 %) | 9 (30 %) |
No | 1 (6.7 %) | 21 (70 %) |
Adjuvant therapy | ||
No | 10 (66.7 %) | 15 (50 %) |
Radiation | 1 (6.7 %) | 5 (16.7 %)a |
Chemotherapy | 4 (26.7 %) | 14 (46.7 %)a |